Geoffrey Dusheiko (K Agarwal, Kosh Agarwal)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Topics

End Stage Renal Disease

Ejection Fraction

Prognostic Factors

African American

Top Venues

Journal of viral hepatitis

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ivana Carey, Moigboi Christiana, McLeod Marie-Ange, Bowyer Teresa, Guerra Veloz Maria, Geoffrey Dusheiko, Geoffrey Dusheiko
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi-ethnic population: Universal screening is more comprehensive. Journal of viral hepatitis 29 (12) (2022)
Ivana Carey, Jeffrey Gersch, Bo Wang, Christiana Moigboi, Mary C Kuhns, Gavin Cloherty, Geoffrey Dusheiko, Geoffrey Dusheiko
Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy. Hepatology (Baltimore, Md.) 72 (1) (2021)
Philip James Johnson, Sarah Berhane, Alex J Walker, Fiona H Gordon, Steven D Ryder, McPherson Stuart, Aravamuthan Sreedharan, Andrew A Ustianowski, Geoffrey Dusheiko, David Mutimer, Takashi Kumada, Hidenori Toyoda, William Lucien Irving, null null
Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection. Journal of viral hepatitis 28 (1) (2020)
Kathryn Drysdale, Yevedzo Ntuli, Jonathan Bestwick, William Gelson, Geoffrey Dusheiko, Daniel M Forton, David Mutimer, Ahmed Mohamed Elsharkawy, Ceri Townley, Faizel Mahomed, Graham R Foster
English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed. Alimentary pharmacology & therapeutics 52 (1) (2020)
Ali Jibran Mecci, Polychronis Kemos, Clifford Leen, Adam Lawson, Paul Richardson, Salim I Khakoo, Geoffrey Dusheiko, David Mutimer, William M Rosenberg, Graham R Foster, William Lucien Irving, null null
The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis. Alimentary pharmacology & therapeutics 50 (2) (2019)
Geoffrey Dusheiko, S H Ahn, M Elkhashab, A H Lau, A Gaggar, A Bulusu, X Tian, A L Cathcart, J Woo, G M Subramanian, Pietro Andreone, H J Kim, W L Chuang, Mindie H Nguyen
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment. Journal of viral hepatitis 25 (11) (2018)
Nancy S Reau, Paul Y Kwo, Susan Rhee, Robert S Brown, Geoffrey Dusheiko, Peter Angus, Edward Gane, Jia-Horng Kao, Parvez S Mantry, David Mutimer, Rajender K Reddy, Tram T Tran, Yiran B Hu, Abhishek Gulati, Preethi Krishnan, Emily O Dumas, Ariel Porcalla, Nancy S Shulman, Wei Liu, Suvajit Samanta, Roger Trinh, Xavier Forns
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology (Baltimore, Md.) 68 (4) (2018)
Steven Flamm, David Mutimer, Armen Asatryan, Stanley Wang, Jürgen Rockstroh, Yves Horsmans, Paul Y Kwo, Ola Weiland, Erica Villa, Jeong Heo, Edward Gane, Stephen D Ryder, Tania M Welzel, Peter J Ruane, Geoffrey Dusheiko, Teresa I Ng, Zhenyi Xue, Sandra S Lovell, Preethi Krishnan, Sarah Kopecky-Bromberg, Roger Trinh, Federico J Mensa, David L Wyles
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis. Journal of viral hepatitis 26 (3) (2018)
Ivana Carey, R Byrne, K Childs, M Horner, M Bruce, Bo Wang, G Dusheiko, Geoffrey Dusheiko
Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B. Journal of viral hepatitis 25 (10) (2018)
Arash Vaziri, Alexander Gimson, Geoffrey Dusheiko, Mark Aldersley, Andrew Bathgate, Douglas MacDonald, McPherson Stuart, David Mutimer, William Gelson
Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy. Journal of viral hepatitis 26 (2) (2018)
Bo Wang, I Carey, M Bruce, S Montague, G Dusheiko, Geoffrey Dusheiko
HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues. Journal of viral hepatitis 25 (8) (2018)